Study Assesses Risk Factors for Depression Among HSCT Survivors

Current presence of pain was associated with both greater depression and fatigue in survivors of hematopoietic stem cell transplantation.
Current presence of pain was associated with both greater depression and fatigue in survivors of hematopoietic stem cell transplantation.

Current presence of pain was independently associated with both greater depression and fatigue in survivors of allogeneic and autologous hematopoietic stem cell transplantation (HSCT), a study published online ahead of print in the journal Cancer has shown.1

Although patients treated with HSCT often experience depression and fatigue, studies to assess the risk factors have been inconclusive due to lack of statistical power. Therefore, researchers sought to examine sociodemographic and clinical risk factors for depression and fatigue in a large cohort of HSCT survivors.

Investigators measured depression and fatigue using data from an annual survey of 1869 HSCT recipients that also included self-reported sociodemographic characteristics and health information. Researchers obtained the participants' clinical characteristics from a clinical database.

Results showed that 13% of participants reported moderate to severe depression, while 42% reported moderate to severe fatigue.

Researchers found that among allogeneic HSCT recipients, female sex, younger age, current presence of chronic pain, and current patient-reported severity of chronic graft-versus-host disease (GVHD) were independently associated with greater depression, while female sex, current presence of chronic pain, and current severity of chronic GVHD were associated with greater fatigue (P<.01).

Furthermore, younger age and current presence of chronic pain were independently associated with both greater depression and greater fatigue among recipients of autologous HSCT (P<.01).

“Rates of depression and fatigue in this group of survivors suggest a high symptom burden,” the authors conclude. “Better screening, referral, and interventions are needed.”

REFERENCE

1. Jim HS, Sutton SK, Jacobsen PB, et al. Risk factors for depression and fatigue among survivors of hematopoietic cell transplantation [published online ahead of print January 27, 2016]. Cancer. doi:10.1002/cncr.29877.

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs